Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-17

Clinical Trial Update: Telephone-administered Relapse Prevention for Depression [NA]

View source ↗

Summary

A completed clinical trial evaluating telephone-administered relapse prevention for depression conducted by the University of Zurich.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Zurich | Conditions: Depressive Disorder | NA | Status: COMPLETED